List of bibliographic references indexed by Utilisation hors indication (MeSH)
Number of relevant bibliographic references: 20.
| Ident. | Authors (with country if any) | Title |
|---|
| 000026 (2021) |
M. Bovet [Allemagne] ; D. Wadsack [Allemagne] ; F. Kosely [Allemagne] ; W. Zink [Allemagne] ; R. Zahn [Allemagne] | [Fatal course of COVID-19 despite IL-6 receptor blockade in cytokine storm : Perimyocarditis and coagulopathy after administration of tocilizumab]. |
| 000093 (2021) |
Derek Shyr [États-Unis] ; Yu Shyr [États-Unis] | The design and analysis of non-randomized studies: a case study of off-label use of hydroxychloroquine in the COVID-19 pandemic. |
| 000105 (2021) |
Nour K. Younis [Liban] ; Rana O. Zareef [Liban] ; Mohammad Ali N. Maktabi [Liban] ; Rami Mahfouz [Liban] | The Era of the Coronavirus Disease 2019 Pandemic: A Review on Dynamics, Clinical Symptoms and Complications, Diagnosis, and Treatment. |
| 000153 (2021) |
Kavita Manchanda [Inde] ; Jasbir Singh [Inde] ; Ranjeev Bhagat [Inde] ; Ilmjot Kaur Tiwana [Inde] ; Harmanjit Singh [Inde] | Safety of pharmacological options for the management of COVID-19 in pregnant women: An Indian perspective. |
| 000216 (2021) |
Eamon Duffy [Nouvelle-Zélande] ; Nicola Arroll [Nouvelle-Zélande] ; Richard Beasley [Nouvelle-Zélande] ; Thomas Hills [Nouvelle-Zélande] | Regulatory Action to Protect Access to Hydroxychloroquine for Approved Rheumatic Indications During COVID-19 in New Zealand. |
| 000295 (2021) |
Zheng Zequn [République populaire de Chine] ; Wu Yujia [République populaire de Chine] ; Qian Dingding [République populaire de Chine] ; Lian Jiangfang [République populaire de Chine] | Off-label use of chloroquine, hydroxychloroquine, azithromycin and lopinavir/ritonavir in COVID-19 risks prolonging the QT interval by targeting the hERG channel. |
| 000296 (2021) |
Victoria Birlutiu ; Rares Mircea Birlutiu ; Liana Chicea [Roumanie] | Off-label tocilizumab and adjuvant iron chelator effectiveness in a group of severe COVID-19 pneumonia patients: A single center experience. |
| 000611 (2021) |
Mary Kelly [Irlande (pays)] ; R Isìn O'Connor [Irlande (pays)] ; Liam Townsend [Irlande (pays)] ; Miriam Coghlan [Irlande (pays)] ; Eileen Relihan [Irlande (pays)] ; Miriam Moriarty [Irlande (pays)] ; Bernard Carr [Irlande (pays)] ; Gail Melanophy [Irlande (pays)] ; Caitriona Doyle [Irlande (pays)] ; Ciaran Bannan [Irlande (pays)] ; Ruth O'Riordan [Irlande (pays)] ; Concepta Merry [Irlande (pays)] ; Susie Clarke [Irlande (pays)] ; Colm Bergin [Irlande (pays)] | Clinical outcomes and adverse events in patients hospitalised with COVID-19, treated with off-label hydroxychloroquine and azithromycin. |
| 000862 (2020) |
Amit Dang [Inde] ; B N Vallish [Inde] ; Sumit Dang [États-Unis] | Hydroxychloroquine and Remdesivir in COVID-19: A critical analysis of recent events. |
| 000885 (2020) |
Alexandre Gérard [France] ; Serena Romani [France] ; Audrey Fresse [France] ; Delphine Viard [France] ; Nadège Parassol [France] ; Aurélie Granvuillemin [France] ; Laurent Chouchana [France] ; Fanny Rocher [France] ; Milou-Daniel Drici [France] | "Off-label" use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers. |
| 000C49 (2020) |
Matthew Mclaughlin | Safe and effective medication utilization in pediatric patients requiring rehabilitation services during the Coronavirus pandemic of 2019. |
| 000F14 (2020) |
Jonathan D. Alpern [États-Unis] ; Elie Gertner [États-Unis] | Off-Label Therapies for COVID-19-Are We All In This Together? |
| 000F15 (2020) |
Francisco José Roma Paumgartten [Brésil] ; Ana Cecilia Amado Xavier De Oliveira [Brésil] | Off label, compassionate and irrational use of medicines in Covid-19 pandemic, health consequences and ethical issues. |
| 000F76 (2020) |
Natalia Marto ; Emília C. Monteiro | Medicines for the Treatment Of COVID-19: Awaiting the Evidence. |
| 001084 (2020) |
Sylvia Lacourse [États-Unis] ; Grace John-Stewart [États-Unis] ; Kristina M. Adams Waldorf [États-Unis, Suède] | Importance of Inclusion of Pregnant and Breastfeeding Women in COVID-19 Therapeutic Trials. |
| 001172 (2020) |
Frank H. Annie [États-Unis] ; Cristian Sirbu [États-Unis] ; Keely R. Frazier [États-Unis] ; Mike Broce [États-Unis] ; B Daniel Lucas [États-Unis] | Hydroxychloroquine in Hospitalized Patients with COVID-19: Real-World Experience Assessing Mortality. |
| 001229 (2020) |
Yves S J. Aquino [Oman] ; Nicolo Cabrera [États-Unis] | Hydroxychloroquine and COVID-19: critiquing the impact of disease public profile on policy and clinical decision-making. |
| 001299 (2020) |
Drew Kuraitis [États-Unis] ; Andrea Murina [États-Unis] | Facts, not Fear: Safety of Hydroxychloroquine. |
| 001401 (2020) |
Benjamin N. Rome [États-Unis] ; Jerry Avorn [États-Unis] | Drug Evaluation during the Covid-19 Pandemic. |
| 001846 (2020) |
Ali Aminian [États-Unis] ; Mohammad Kermansaravi [Iran] ; Shahriar Azizi [Iran] ; Peyman Alibeigi [Iran] ; Sina Safamanesh [Iran] ; Ali Mousavimaleki [Iran] ; Mohammad Taghi Rezaei [Iran] ; Maziar Faridi [Iran] ; Somayeh Mokhber [Iran] ; Abdolreza Pazouki [Iran] ; Saeed Safari [Iran] | Bariatric Surgical Practice During the Initial Phase of COVID-19 Outbreak. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i -k "Utilisation hors indication (MeSH)"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i \
-Sk "Utilisation hors indication (MeSH)" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidChloroV1
|flux= Main
|étape= Exploration
|type= indexItem
|index= KwdFr.i
|clé= Utilisation hors indication (MeSH)
}}
| This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021 |  |
